Project Number EUJPND-European Commission-EC Grant-926 Agency/Funding Organization European Commission Funding Year 2016 View Full Project Details for A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator EC Grant Principal Investigator First Name EC Grant Principal Investigator Last Name EC Grant Awardee Organization EC Grant Contact PI Country Multi-national Project Detail Funding Opportunity Announcement European Commission FP7-Seventh Framework Programme FY Overall Cost $1,091,177 Funding Organization Agency/Funding Organization European Commission Funding Organization Country Multi-national Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
